The Power of Partnerships: Why Pharma Needs to Redefine its Role With IDNs
John Griggs co-authored this article with Dinesh Kabaleeswaran. This article was originally published on Drug Channels. Large healthcare conglomerates, or integrated delivery networks (IDNs), have long been fixtures in the market access landscape—a dynamic that has gone unchanged despite the disruption caused by COVID-19. While M&A activity slowed down during 2020, IDNs are seeing a bout […]
What to Expect at This Year’s Asembia Specialty Pharmacy Summit
The COVID-19 pandemic has been an unrelenting trial—one that, in many ways, accelerated the pace of change in the life sciences industry. In the wake of breathtakingly fast novel vaccine development, an abrupt shift toward virtual care and a renewed focus on digital therapeutics, things look vastly different than they did less than two years […]